32 studies found for:    " June 24, 2009":" July 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" June 24, 2009":" July 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (32 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Enrolling by invitation The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
Conditions: HIV Positive;   Anal Condylomata;   Anal Warts;   HIV Infections
Interventions: Drug: Saline;   Drug: Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
2 Completed Integration of Family Planning and HIV Services in Tanzania
Conditions: HIV Infection;   HIV Infections
Intervention: Behavioral: Facilitated Referral
3 Active, not recruiting HIV Viral Load Monitoring in Resource-Poor Settings
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: HIV-1 viral load testing
4 Unknown  Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)
Conditions: HIV;   Lung;   HIV Infections
Intervention: Behavioral: Smoking Cessation
5 Completed Switch From Tenofovir to Raltegravir for Low Bone Mineral Density
Conditions: HIV;   Osteopenia;   Osteoporosis;   HIV Infections
Intervention: Drug: Raltegravir
6 Active, not recruiting Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens
Conditions: Pediatric HIV;   HIV Infections
Intervention: Drug: Boosted Atazanavir
7 Unknown  Preparing for Adolescent HIV Vaccine Trials in South Africa:
Conditions: HIV Infection;   HIV Infections
Intervention:
8 Withdrawn Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
Conditions: HIV Infection;   Pregnancy;   Breastfeeding;   HIV Infections
Interventions: Drug: Efavirenz-Tenofovir-Emtricitabine;   Drug: Zidovudine-Lamivudine-Lopinavir/Ritonavir
9 Completed Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Intervention: Behavioral: Tailored Information Program for Safer Sex
10 Completed Study of Bone Disease in Older HIV-infected Adults
Conditions: Osteopenia;   Osteoporosis;   HIV Infection;   Aging;   HIV Infections
Intervention:
11 Completed Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: raltegravir QD;   Drug: atazanavir;   Drug: lamivudine (or emtricitabine)
12 Completed Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: maraviroc
13 Terminated Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
Conditions: HIV1 Infection;   HIV Infections
Intervention:
14 Completed Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
Conditions: Herpes Simplex Type Two Infection;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
15 Completed IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients
Condition: HIV Infections
Interventions: Drug: Isentress®;   Drug: Celsentri®
16 Completed Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya
Condition: HIV Infections
Intervention: Procedure: Integrated ANC, PMTCT, HIV services
17 Completed Effect of Antacids on the Pharmacokinetics of Raltegravir
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: antacid
18 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
Condition: HIV Infection
Interventions: Drug: FTC/TDF;   Drug: Placebo
19 Unknown  Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Conditions: Cervical Cancer Screening;   HIV Infections
Intervention:
20 Unknown  Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz
Conditions: Sleep Disorders;   HIV Infections
Interventions: Drug: Raltegravir for the first 2 weeks;   Drug: Efavirenz for the last 2 weeks;   Drug: Efavirenz for the first 2 weeks;   Drug: Raltegravir for the last 2 weeks

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years